glp-1 hunger Electric Elixir Weight Loss Supplement with Akkermansia Are GLP-1 weight-loss drugs quietly

Reduction in Risk Across Fourteen Obesity-Related Cancers A large observational study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025, involving more than 170,000 patients with diabetes and obesity, found that GLP-1 receptor agonists were associated with a modest but statistically meaningful reduction in the incidence of 14 obesity-related cancers , with colorectal cancer demonstrating particularly favourable outcomes when compared to patients receiving DPP-4 inhibitors

These results were confirmed by RT-PCR analysis (Fig

Conclusion of Current Study The current study showed that the most noticeable effect of carnitine was on sperm motility, likely due to its known mechanisms in energy production and antioxidant activity

Although the tool doesn't chip away at the shortage problem, it provides insights to patients and providers working to obtain access to the medications

If these develop while taking supplements, they warrant medical assessment to rule out ongoing deficiency or other neurological conditions